KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1666-1675

  Sellak, Hassan ^a   Wu, Songwei ^b   Lincoln, Thomas M ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

catenin; Cancer; KLF4; Sox9; T cell factor; Wnt signaling

Indexed keywords

BETA CATENIN; KRUPPEL LIKE FACTOR 4; LUCIFERASE; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR SOX9;

ARTICLE; CANCER CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; BINDING, COMPETITIVE; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUCIFERASES; OLIGONUCLEOTIDES; PROTEIN BINDING; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 84864507806     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.06.027     Document Type: Article

References (49)

1. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 2006, 27:469-480. (Review).
2. MacDonald B.T., Tamai K., He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
3. Hecht A., Kemler R. Curbing the nuclear activities of β-Catenin control over Wnt target gene expression. EMBO Rep. 2001, 1:24-28.
4. Evans P.M., Chen X., Zhang W., Liu C. KLF4 interacts with β-catenin/TCF4 and blocks p300/CBP recruitment by β-catenin. Mol. Cell. Biol. 2010, 30:372-381.
5. Henderson B.R., Fagotto F. The ins and outs of APC and β-catenin nuclear transport. EMBO Rep. 2002, 3:834-839. (Review).
6. Shields J.M., Christy R.J., Yang V.W. Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J. Biol. Chem. 1996, 271:20009-20017.
7. Serge J.A., Bauer C., Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 1999, 22:356-360.
8. Huang C.C., Liu Z., Li X., Bailey S.K., Nail C.D., Foster K.W., Foster A.R., Ruppert J.M., Lobo-Ruppert S.M. KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol. Ther. 2005, 4:1401-1408.
9. Moon R.T., Kohn A.D., De Ferrari G.Y., Kaykas A. WNT and β-catenin signaling: disease and therapies. Nat. Rev. Genet. 2004, 5:691-701.
10. Wodarz A., Nusse R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 1998, 4:59-88.
11. Chen X., Johns D.C., Geiman D.E., Marban E., Dang D.T., Hamlin G., Sun R., Yang V.W. Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 2001, 276:30423-30428.
12. Zhao W., Hisamuddin I.M., Nandan M.O., Babbin B.A., Lamb N.E., Yang V.W. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004, 2:395-402.
13. Dang D.T., Chen X., Feng J., Torbenson M., Dang L.H., Yang V.W. Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenicity. Oncogene 2003, 22:3424-3430.
14. Ghaleb A.M., McConnell B.B., Nandan M.O., Katz J.P., Kaestner K.H., Yang V.W. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res. 2007, 67:7147-7154.
15. Wei D., Gong W., Kanai M., Schlunk C., Wang L., Yao J.C., Wu T.T., Huang S., Xie K. Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005, 65:2746-2754.
16. Ohnishi S., Ohnami S., Laub F., Aoki K., Suzuki K., Kanai Y., Haga K., Asaka M., Ramirez F., Yoshida T. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun. 2003, 308:25-56.
17. Pandya A.Y., Talley L.I., Frost E.R., Fitzgerald T.J., Trivedi V., Chakravarthy M., Chhieng D.C., Grizzle W.E., Engler J.A., Krontiras H., Bland K.I., LoBuglio A.F., Lobo-Ruppert S.M., Ruppert J.M. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res. 2004, 10:2709-2719.
18. Foster K.W., Frost A.R., McKie-Bell P., Lin C.Y., Engler J.A., Grizzle W.E., Ruppert J.M. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 2000, 60:6488-6495.
19. Zhang W., Chen X., Kato Y., Eva P.M., Yuan S., Yang J., Rychahou P.G., Yang V.W., He X., Evers B.M., Liu C. Novel cross talk of KLF4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol. Cell. Biol. 2006, 26:2055-2064.
20. Stone C., Chen Z.Y., Tseng C.C. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway. FEBS Lett. 2002, 530:147-152.
21. Flandez M., Guilmeau S., Blache P., Augenlicht L.H. KLF4 regulation in intestinal epithelial cell maturation. Exp. Cell Res. 2008, 314:3712-3723.
22. Yori J.L., Seachrist D.D., Johnson E., Lozada K.L., Abdul-Karim F.W., Chodosh L.A., Scchiemann W.P., Keri R.A. Krüppel-like Factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 2011, 13:601-610.
23. Kormish J.D., Sinner D., Zorn A.M. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev. Dyn. 2010, 239:56-68.
24. Sinner D., Kordich J.J., Spence J.R., Opoka R., Rankin S., Lin S.C., Jonatan D., Zorn A.M., Wells J.M. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell. Biol. 2007, 27:7802-7815.
25. Lu B., Fang Y., Xu J., Wang L., Xu F., Xu E., Huang Q., Lai M. Analysis of SOX9 expression in colorectal cancer. Am. J. Clin. Pathol. 2008, 130:897-904.
26. Jay P., Berta P., Blache P. Expression of the carcino-embryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells. Cancer Res. 2005, 65:2193-2198.
27. Drivdahl R., Haugk K.H., Sprenger C.C., Nelson P.S., Tennant M.K., Plymate S.R. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Oncogene 2004, 23:4584-4593.
28. Blache P., Van De Wetering M., Duluc I., Domon C., Berta P., Freund J.N., Clevers H., Jay P. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 gene. J. Cell Biol. 2004, 166:37-47.
29. Afonja O., Raaka B.M., Huang A., Das S., Zhao X., Helmer E., Juste D., Samuels H.H. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Oncogene 2002, 51:7850-8760.
30. Akiyama H., Lyons J.P., Mori-Akiyama Y., Yang X., Zhang R., Zhang Z., Deng J.M., Taketo M.M., Nakamura T., Behringer R.R., McCrea P.D., Crombrugghe B. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 2004, 18:1072-1087.
31. Topol L., Chen W., Song H., Day T.F., Yang Y. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J. Biol. Chem. 2009, 284:3323-3333.
32. Clevers H., Van de Wetering M. TCF/LEF factors earn their wings. Trends Genet. 1997, 13:485-489.
33. Harley V.R., Lovell-Badge R., Goodfellow P.N. Definition of a consensus DNA binding site for SRY. Nucleic Acids Res. 1994, 22:1500-1501.
34. Takash W., Canizares J., Bonneaud N., Poulat F., Mattei M.G., Jay P., Berta P. SOX7 transcription factor: sequence, chromosomal localization, expression, transactivation and interference with Wnt signaling. Nucleic Acids Res. 2001, 29:4274-4283.
35. Zorn A.M., Barish G.D., Williams B.O., Lavender P., Klymkowsky M.W., Varmus H.E. Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol. Cell 1999, 4:487-498.
36. Mertin S., McDowall G.S., Harley R.V. The DNA binding specificity of Sox9 and other Sox proteins. Nucleic Acids Res. 1999, 27:1359-1364.
37. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999, 27:1409-1420.
38. Xu W., Kimelman D. Mechanistic insights from structural studies of beta-catenin and its binding partners. J. Cell Sci. 2007, 120:3337-3343.
39. Morin P.J., Weeraratna A.T. Wnt signaling in human cancer. Cancer Treat. Res. 2003, 115:169-187.
40. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochem. Biophys. Acta 2003, 1653:1-24.
41. Yu F., Ji L., Chen H., Fu J., Ray S., Huang S., Zheng H., Ai W. Krüppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 2011, 30:2161-2172.
42. Rowland B.D., Bernards R., Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 2005, 7:1074-1082.
43. Vangapandu H., Ai W. Krüppel like factor 4 (KLF4): a transcription factor with diverse context-dependent functions. Gene Ther. Mol. Biol. 2009, 13:94-104.
44. Ghaleb A.M., Nandan M.O., Chanchevalap S., Dalton W.B., Hisamuddin I.M., Yang V.W. Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 2005, 15:92-96.
45. Passeron T., Valencia J.C., Namiki T., Vieira W.D., Passeron H., Miyamura Y., Hearing V.J. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J. Clin. Invest. 2009, 119:954-963.
46. Matheu A., Collado M., Wise C., Manterola L., Cekaite L., Tye A.J., Canamero M., Bujanda L., Schedl A., Cheah K.S.E., Skotheim R.I., Lothe R.A., de Munain A.L., Briscoe J., Serrano M., Lovell-Badge R. Oncogenicity of the developmental transcription factor Sox9. Cancer Res. 2012, 72:1301-1315.
47. Wang H., Leav I., Ibaragi S., Wegner M., Hu G.F., Lu M.L., Balk S.P., Yuan X. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res. 2008, 68:1625-1630.
48. Jiang S.S., Fang W.T., Hou Y.H., Huang S.F., Yen B.L., Chang J.L., Li S.M., Liu H.P., Liu Y.L., Huang C.T., Li Y.W., Jang T.H., Chan H.H., Yang S.J., Hsiung C.A., Wu C.W., Wang L.H., Chang I-S Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin. Cancer Res. 2010, 16:4363-4373.
49. Maatok D.M., DiNopoli L., Alvers A., Parker K.L., Taketo M.M., Capel B. Stabilization of β-catenin in XY gonads causes molecular sex reversal. Hum. Mol. Genet. 2008, 17:2949-2955.